# 1/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial

> **NIH NIH R01** · SEATTLE CHILDREN'S HOSPITAL · 2020 · $709,509

## Abstract

ABSTRACT/PROJECT SUMMARY
Maternal ADHD, present in 25-50% of families of children with ADHD and frequently untreated, interferes with
effective parenting and predicts poor child developmental and behavioral treatment outcomes. Based on the
literature and our own pilot data, we will randomly assign mothers with ADHD and their young at-risk children
to one of two conditions: (1) stimulant medication for mothers with ADHD followed by a child treatment strategy
(CTS) beginning with behavioral parent training (BPT) with the added recommendation of child stimulant
treatment if the child remains impaired or (2) a CTS without treatment for maternal ADHD on parent, child, and
family outcomes. We will examine target mechanisms including improvements in maternal ADHD-related
impairment and symptomatology (attention, impulsivity, emotional regulation), parenting skills, and BPT
engagement, as well as treatment moderators (baseline maternal ADHD severity, maternal impairment, and
parenting skills). Moreover, in an effort to develop a model of treatment that has potential for widespread
dissemination while also reducing barriers to receiving care, we will screen mothers for ADHD in primary care,
where child ADHD is most often identified and treated, and co-located mental health providers will deliver
treatments via telehealth. Development of an implementation plan and associated toolkit using a stakeholder
participatory strategy will enhance the ability to move efficiently to adoption of this approach. In addition, we
will study the care delivery context, assessing procedures for and rates of screening and participation as well
as staffing, workflow, provider- and patient-level acceptability, readiness, and feasibility of implementation
approaches. This hybrid effectiveness-implementation project will be achieved via a collaborative R01 across 2
research sites in the US (N = 240 families), with 4-5 primary care partners at each site.

## Key facts

- **NIH application ID:** 9990850
- **Project number:** 5R01MH118313-02
- **Recipient organization:** SEATTLE CHILDREN'S HOSPITAL
- **Principal Investigator:** MARK A STEIN
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $709,509
- **Award type:** 5
- **Project period:** 2019-08-07 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9990850

## Citation

> US National Institutes of Health, RePORTER application 9990850, 1/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial (5R01MH118313-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9990850. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*